Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05426031 · ClinicalTrials.gov registry record · Phase 4
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
NCT05426031: Completed Phase 4 study, sponsored by University of Miami.
NCT05426031 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 130 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05426031, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two different dosing strategies of a drug named protamine.
Primary Outcome
Activated clotting times will be measured using standard coagulation monitor
Interventions
- DRUG Protamine fixed dose
- DRUG Protamine ratio dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2022-06-28 |
| Est. Completion | 2023-06-01 |
| Phase | Phase 4 |
What the finished NCT05426031 record still lists
NCT05426031 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Protamine fixed dose is the first listed.
NCT05426031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05426031 about?
NCT05426031 is a clinical study titled "Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass". The purpose of this study is to compare two different dosing strategies of a drug named protamine.
What is the current status of trial NCT05426031?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2022-06-28. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT05426031?
The interventions under investigation include: Protamine fixed dose (DRUG), Protamine ratio dose (DRUG).
Who is sponsoring clinical trial NCT05426031?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05426031's enrollment target sits among peer trials
130 622nd of 2000 higher than 1,370 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI